Rosenblatt analyst Blair Abernethy downgraded Synopsys (SNPS) to Neutral from Buy with a price target of $605, down from $650.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys price target lowered to $550 from $650 at Stifel
- Synopsys price target lowered to $630 from $660 at Piper Sandler
- Synopsys double downgraded to Underperform at BofA on Intel, China overhangs
- Synopsys price target lowered to $550 from $630 at Wells Fargo
- Synopsys: Navigating Challenges with Optimism and Growth Potential